首页> 外文期刊>Diagnostic microbiology and infectious disease >Staphylococcus aureus versus Staphylococcus epidermidis in periprosthetic Check for joint infection-Outcome analysis of methicillin-resistant versus methicillin-susceptible strains
【24h】

Staphylococcus aureus versus Staphylococcus epidermidis in periprosthetic Check for joint infection-Outcome analysis of methicillin-resistant versus methicillin-susceptible strains

机译:金黄色葡萄球菌与葡萄球菌的葡萄球菌对甲氧西林抗性与甲氧西林易感菌株的关节感染结果分析

获取原文
获取原文并翻译 | 示例
           

摘要

Periprosthetic joint infections (PJIs) are a major complication in total joint arthroplasty. Staphylococcus aureus and coagulase-negative staphylococci are known to cause the majority of all PJIs This study aimed to analyze the eradication rates of S. aureus and S. epidermidis with methicillin susceptibility and methicillin resistance in a 2-stage therapy algorithm. Seventy-four patients with PJI caused by methicillin-resistant S. aureus (MRSA), methicillin-resistant coagulase-negative staphylococci (MRSE), methicillin-susceptible S. aureus (MSSA), and methicillin-susceptible coagulase-negative staphylococci (MSSE) were included, and the outcome was analyzed retrospectively. After a minimal follow-up of 2 years, n = 56 patients (75.7%) were definitively free of infection. The analysis revealed significant differences between the groups, with eradication rates as follows: MSSA (92.6%), MSSE (95.2%), MRSA (80%), and MRSE (54.2%). MRSE showed a significantly lower rate of patients graded as "definitively free of infection" as compared to patients with infections caused by MSSA, MSSE, and MRSA. (C) 2018 Elsevier Inc. All rights reserved.
机译:Periprosithetth的关节感染(PJI)是总关节造身术中的主要复杂性。众所周知,金黄色葡萄球菌和凝固酶阴性葡萄球菌导致所有PJIS的大多数本研究旨在分析2-阶段治疗算法中甲氧西林易感性和甲氧西林抗性的S.金黄色葡萄球菌和S.表皮的根除率。七十四名患有甲氧西林耐金黄色葡萄球菌(MRSA),耐甲氧西林凝固酶阴性葡萄球菌(MRSE),甲氧西林 - 易感金黄色葡萄球菌(MSSA)和甲氧西林 - 敏感凝血酶阴性葡萄球菌(MSSE)包括在内,回顾性地分析结果。在2年的最小随访后,N = 56名患者(75.7%)明确无感染。该分析显示,组之间的显着差异,具有脱离率,如下:MSSA(92.6%),MSSE(95.2%),MRSA(80%)和MRSE(54.2%)。与MSSA,MSSE和MRSA引起的感染患者相比,MRSE表现出显着降低的患者患者“明确的感染”。 (c)2018年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号